PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
24
Frequently Asked Questions
What is Market Cap of PDS Biotechnology Corporation?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. PDS Biotechnology Corporation market cap is $49.38M.
What is the 52-week high for PDS Biotechnology Corporation?
52 week high is the highest price of a stock in the past 52 weeks, or one year. PDS Biotechnology Corporation 52 week high is $4.29 as of September 20, 2025.
What is the 52-week low for PDS Biotechnology Corporation?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PDS Biotechnology Corporation 52 week low is $0.8505 as of September 20, 2025.
What is PDS Biotechnology Corporation stock price today?
PDS Biotechnology Corporation stock price today is $1.05.
What was PDS Biotechnology Corporation stock price yesterday?
PDS Biotechnology Corporation stock price yesterday was $1.15.
What is the PE ratio of PDS Biotechnology Corporation?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. PDS Biotechnology Corporation’s P/E ratio is -1.15.
What is the Price-to-Book ratio of PDS Biotechnology Corporation?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. PDS Biotechnology Corporation P/B ratio is 3.0680.
What is the 50-day moving average of PDS Biotechnology Corporation?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. PDS Biotechnology Corporation 50-day moving average is $1.18.
How many employess does PDS Biotechnology Corporation has?
